Key result
Clopidogrel and statins linked to lower mortality in older CAD patients without low GFR.
Why the study?
The study was designed to investigate the relationship between drug application and mortality rate in Chinese older CAD/CHF patients with and without low GFR.
Does the application of cardiovascular drugs reduce mortality in older Chinese CAD/CHF patients with and without low GFR?
Observational (n=1,377)
Does the application of cardiovascular drugs reduce mortality in older Chinese CAD/CHF patients with and without low GFR?
Answers are grounded in this paper and cite their sources.
Clopidogrel and statins are associated with reduced mortality in older Chinese CAD/CHF patients with preserved renal function, but this benefit is attenuated in those with low GFR.
BACKGROUND: This analysis was designed to investigate the relationship between drug application and mortality rate in Chinese older coronary artery disease (CAD)/chronic heart failure (CHF) patients with and without low glomerular filtration rate (GFR). METHODS: . RESULTS: There were 372 patients (35.4%) with low GFR in patients with CAD (1050 patients), and 168 patients (51.4%) in patients with CHF (327 patients). In CAD patients without low GFR, clopidogrel [P = 0.028, odds ratio (OR): 0.620, 95% confidence interval (CI): 0.404-0.951] rather than aspirin (P = 0.173) was significantly associated with lower mortality rate. Statins (P < 0.001, OR: 0.287, 95% CI: 0.180-0.456) were significantly associated with lower mortality rate. In CAD patients with low GFR, aspirin, clopidogrel and statins had no significant relationship with mortality rate (P > 0.05 for all). In CHF patients without low GFR, statins were significantly associated with lower mortality rate (P < 0.001, OR: 0.220, 95% CI: 0.098-0.490). In CHF patients with low GFR, statins had no significant relationship with mortality rate (P > 0.05 for all). CONCLUSION: Clopidogrel but not aspirin was beneficial in Chinese older CAD patients without low GFR rather than those with low GFR, and statins benefited for Chinese older CAD/CHF patients without low GFR rather than those with low GFR. These discoveries might offer some help for the therapy of Chinese older patients with cardiovascular/renal diseases.
No takes yet. Share an insight, caveat, or question.
Fu et al. (2019) conducted an observational in Coronary artery disease (CAD) and chronic heart failure (CHF) (n=1,377). Clopidogrel, aspirin, and statins vs. Non-use was evaluated on Mortality rate (OR 0.620, 95% CI 0.404-0.951, p=0.028). Clopidogrel and statins were associated with lower mortality in older Chinese CAD patients without low GFR, but not in those with low GFR.
Synapse has enriched 10 related papers. Consider them for comparative context: